Long-term topical management of psoriasis: the road ahead.

Abstract

Topical therapies have been available for the treatment of psoriasis for several decades. Despite this and the availability of several types of topicals, with varying potency, and numerous vehicles of administration, the majority of clinical data and guidance is on short-term use in the management of psoriasis. The aim of this manuscript is to review the unmet needs that exist in the long-term management of psoriasis and provide the dermatology community with an understanding that a treatment regimen with topical therapies could be the best treatment option at least for some phases of this chronic relapsing disease. We present a 'call to action' on the need for clinical alignment on terminology in the field and recommend the term 'long-term management' be adopted as the most appropriate in the context of this manuscript. This expert opinion report provides a detailed review of the limited evidence available regarding long-term use of topical therapies for the management of psoriasis, alongside our key considerations and recommendations to assist dermatologists with the implementation of topicals as part of long-term management strategies. Long-term management should be considered mandatory to ensure patients receive appropriate proactive treatment which may help optimize adherence and long-term outcomes.

• Authors: Siegfried Segaert, Piergiacomo Calzavara-Pinton, Pablo de la Cueva, Ahmad Jalili, Dominique Lons Danic, Andrew E Pink, Diamant Thaçi, Melinda Gooderham
• Journal: The Journal of dermatological treatment (J Dermatolog Treat) Vol. 33 Issue 1 Pg. 111-120 (Feb 2022) ISSN: 1471-1753 [Electronic] England
• PMID: 32091278 (Publication Type: Journal Article)

Chemical References

• Dermatologic Agents

Topics

• Administration, Topical
• Dermatologic Agents (therapeutic use)
• Humans
• Psoriasis (drug therapy)